Kelly Huber

495 citations
13 papers · 428 indexed · h-index 9
Topics
HIV Research and Treatment (11 papers)HIV/AIDS drug development and treatment (9 papers)HIV/AIDS Research and Interventions (6 papers)

In The Last Decade

Kelly Huber

12 papers receiving 423 citations

Peers

Kelly Huber
Comparison fields: 5 of 64
  • Virology 252
  • Infectious Diseases 220
  • Molecular Biology 180
  • Organic Chemistry 63
  • Epidemiology 55
Replace Valérie Vivet‐Boudou with:
Valérie Vivet‐Boudou France
Pratiq A. Patel United States
Lily Hong United States
Isaac Zentner United States
S.L. Irving United Kingdom
Takuya Kobayakawa Japan
Valentine V. Courouble United States
Stéphane de Walque Belgium
Pratibha C. Koneru United States
Jeanette Roman United States
Kelly Huber relative to Valérie Vivet‐Boudou France Valérie Vivet‐Boudou's profile →
Citations per field
00.5×1.5×1.8×
Valérie Vivet‐Boudou · 1×
Citations per year

Countries citing papers authored by Kelly Huber

Since Specialization
Citations

This map shows the geographic impact of Kelly Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Huber more than expected).

Fields of papers citing papers by Kelly Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Huber. The network helps show where Kelly Huber may publish in the future.

Co-authorship network of co-authors of Kelly Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Huber. A scholar is included among the top collaborators of Kelly Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Huber. Kelly Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 4
3 23
4 39
5 6
6 54
7 25
8 67
9 10
10 6
11 117
12 9
13 68

About Kelly Huber

Kelly Huber is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 13 papers that have together received 428 indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). The work is most often cited by research in Virology (252 citations), Infectious Diseases (220 citations) and Molecular Biology (180 citations). Kelly Huber has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Nicolas Sluis‐Cremer, John W. Mellors, Geneviève Doyon, Elizabeth Fyne, Grant D. Schauer, Sanford H. Leuba, Peter M. Fischer, Poulam M. Patel, Stephen Chan and Stewart G. Martin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026